BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34263956)

  • 1. Antecedent infections and vaccinations in chronic inflammatory demyelinating polyneuropathy: A European collaborative study.
    Rajabally YA; Peric S; Bozovic I; Loo LK; Kalac A; Palibrk A; Basta I
    Muscle Nerve; 2021 Dec; 64(6):657-661. PubMed ID: 34263956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between acute-onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients.
    Alessandro L; Pastor Rueda JM; Wilken M; Querol L; Marrodán M; Acosta JN; Rivero A; Barroso F; Farez MF
    J Peripher Nerv Syst; 2018 Sep; 23(3):154-158. PubMed ID: 29603827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrences, vaccinations and long-term symptoms in GBS and CIDP.
    Kuitwaard K; Bos-Eyssen ME; Blomkwist-Markens PH; van Doorn PA
    J Peripher Nerv Syst; 2009 Dec; 14(4):310-5. PubMed ID: 20021573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 Vaccination Safety in Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy, and Multifocal Motor Neuropathy.
    Baars AE; Kuitwaard K; de Koning LC; Luijten LWG; Kok WM; Eftimov F; Wieske L; Goedee HS; van der Pol WL; Blomkwist-Markens PH; Horemans AMC; Jacobs BC; van Doorn PA
    Neurology; 2023 Jan; 100(2):e182-e191. PubMed ID: 36127144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two Case Reports of Chronic Inflammatory Demyelinating Polyneuropathy After COVID-19 Vaccination.
    Kim S; Lee EK; Sohn E
    J Korean Med Sci; 2023 Feb; 38(8):e57. PubMed ID: 36852853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): antecedent events, lifestyle and dietary habits. Data from the Italian CIDP Database.
    Doneddu PE; Bianchi E; Cocito D; Manganelli F; Fazio R; Filosto M; Mazzeo A; Cosentino G; Cortese A; Jann S; Clerici AM; Antonini G; Siciliano G; Luigetti M; Marfia GA; Briani C; Lauria G; Rosso T; Cavaletti G; Carpo M; Benedetti L; Beghi E; Liberatore G; Santoro L; Peci E; Tronci S; Cotti Piccinelli S; Toscano A; Piccolo L; Verrengia EP; Leonardi L; Schirinzi E; Mataluni G; Ruiz M; Dacci P; Nobile-Orazio E;
    Eur J Neurol; 2020 Jan; 27(1):136-143. PubMed ID: 31325350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute-Onset Chronic Inflammatory Demyelinating Polyradiculoneuropathy].
    Kanbayashi T; Sonoo M
    Brain Nerve; 2015 Nov; 67(11):1388-96. PubMed ID: 26560954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy.
    Chaudhary UJ; Rajabally YA
    J Neurol; 2021 Apr; 268(4):1366-1373. PubMed ID: 33170339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination.
    Suri V; Pandey S; Singh J; Jena A
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34607818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study on the role of serum uric acid in differentiating acute inflammatory demyelinating polyneuropathy from acute-onset chronic inflammatory demyelinating polyneuropathy.
    Zhang W; Tao W; Wang J; Nie P; Duan L; Yan L
    Eur J Neurol; 2024 May; 31(5):e16222. PubMed ID: 38356316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory demyelinating polyneuropathy after the ChAdOx1 nCoV-19 vaccine may follow a chronic course.
    de Souza A; Oo WM; Giri P
    J Neurol Sci; 2022 May; 436():120231. PubMed ID: 35313224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study.
    Ruts L; Drenthen J; Jacobs BC; van Doorn PA;
    Neurology; 2010 May; 74(21):1680-6. PubMed ID: 20427754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic inflammatory demyelinating polyneuropathy after SARS-CoV2 vaccination: update of the literature and patient characterization.
    Ginanneschi F; Vinciguerra C; Volpi N; Piscosquito G; Barone P; Rossi A
    Immunol Res; 2023 Dec; 71(6):833-838. PubMed ID: 37395901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay.
    Kmezic I; Gustafsson R; Fink K; Svenningsson A; Samuelsson K; Ingre C; Olsson T; Hansson M; Kockum I; Adzemovic MZ; Press R
    Front Immunol; 2023; 14():1241199. PubMed ID: 38077366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
    Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
    Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of IL-17 and IL-34 concentrations in the cerebrospinal fluid of patients with acute inflammatory demyelinating neuropathy and chronic inflammatory demyelinating polyneuropathy.
    Soytürk H; Yılmaz M
    Rev Assoc Med Bras (1992); 2020 Nov; 66(11):1583-1588. PubMed ID: 33295414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute-onset chronic inflammatory demyelinating polyneuropathy: An electrodiagnostic study.
    Anadani M; Katirji B
    Muscle Nerve; 2015 Nov; 52(5):900-5. PubMed ID: 25809534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
    Sainaghi PP; Collimedaglia L; Alciato F; Leone MA; Naldi P; Molinari R; Monaco F; Avanzi GC
    Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients with chronic inflammatory demyelinating polyneuropathy initially diagnosed as Guillain-Barré syndrome.
    Odaka M; Yuki N; Hirata K
    J Neurol; 2003 Aug; 250(8):913-6. PubMed ID: 12928908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL; Zhang XM; Mao XJ; Deng H; Li HF; Press R; Fredrikson S; Zhu J
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.